Enanta Pharmaceuticals (ENTA) Times Interest Earned: 2012-2025
Historic Times Interest Earned for Enanta Pharmaceuticals (ENTA) over the last 8 years, with Sep 2025 value amounting to -$7.70.
- Enanta Pharmaceuticals' Times Interest Earned rose 33.41% to -$7.70 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.11, marking a year-over-year increase of 0.11%. This contributed to the annual value of -$11.11 for FY2025, which is 0.11% up from last year.
- Per Enanta Pharmaceuticals' latest filing, its Times Interest Earned stood at -$7.70 for Q3 2025, which was up 34.04% from -$11.68 recorded in Q2 2025.
- Enanta Pharmaceuticals' Times Interest Earned's 5-year high stood at -$7.70 during Q3 2025, with a 5-year trough of -$18.38 in Q2 2023.
- Over the past 3 years, Enanta Pharmaceuticals' median Times Interest Earned value was -$11.62 (recorded in 2024), while the average stood at -$11.87.
- Examining YoY changes over the last 5 years, Enanta Pharmaceuticals' Times Interest Earned showed a top increase of 44.14% in 2024 and a maximum decrease of 18.36% in 2024.
- Quarterly analysis of 3 years shows Enanta Pharmaceuticals' Times Interest Earned stood at -$10.14 in 2023, then dropped by 18.36% to -$12.00 in 2024, then skyrocketed by 33.41% to -$7.70 in 2025.
- Its Times Interest Earned was -$7.70 in Q3 2025, compared to -$11.68 in Q2 2025 and -$14.31 in Q1 2025.